Introduction to Huber

Stay at the forefront of biopharmaceutical innovation. Subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related to this article

Meeta Gulyani, SVP & GM of Bioprocessing and Head of Life Sciences Strategy at Ecolab Life Sciences, shares where biomanufacturing is headed next and why the relationship between drug developers and their suppliers is changing along with it.

SponsoredSeptember 30th, 2026

The Next Phase of Bioprocessing: Trends Redefining Manufacturing

Meeta Gulyani, Ecolab Life Sciences, shares where biomanufacturing is headed next and why the relationship between drug developers and their suppliers is changing along with it.